Dorothea Katharina Hoffelner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorothea Katharina Hoffelner has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ana Algueró-Nadal
VIB Center for Cancer Biology, Belgium; KU Leuven Department of Oncology, KU Leuven, Belgium
1 shared publication Andreas Völkerer
Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Oberndorf, Austria
1 shared publicationBernhard Scheiner
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Clinical Research Group MOTION, Medical University of Vienna, Vienna, Austria
1 shared publicationBernhard Wernly
First Department of Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Oberndorf, Austria
1 shared publication- Christian Datz
Department of Internal Medicine, Hospital Oberndorf, Teaching Hospital of the Paracelsus Private University of Salzburg, Oberndorf, Austria
1 shared publication Christoph J. Binder
Department of Laboratory Medicine, KILM, Medical University of Vienna, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (9) , 101932
Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk
- 19 June 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (9) , 101932
Open AccessAlcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk
- Open Access
- 6 June 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 83 (5) , 1142-1155
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation
- 6 June 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 83 (5) , 1142-1155
Open AccessSteatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation